Anavex Life Sciences Corp (AVXL)

[falconer66a]

Our postings; and Dr. Hagerman’s.

...Mayo, Xena, Boi, Power, Lima, Bourbon, Sparks, Raja, george, Steady, HMB, Jonjones, Dadof, xo, Ruby, Talon, arrow, infit, rocalinda, Jager, oldandintheway, bb857, Red, and not to forget our old friend Bennyboy, etc.

— Good listing of the many contributors providing positive info supporting the future of Anavex Life Sciences Corp.

I’ve posted a few of those myself. Understandably, outsiders, and those who know little about Anavex science, will be skeptics; discounting the things we post. Too good to be true. Our posts are in one category; but those telling of Dr. Hagerman’s statements about blarcamesine are on a different, much higher plane.

Dr. Hagerman is a world-class expert in the central nervous system diseases she treats and conducts clinical trials on. The good woman hasn’t seen blarcamesine from afar. She’s watched patients in her clinical trials take the drug, and has subsequently studied, first hand, over time, what it does. Her statements are as positive and supportive of blarcamesine as any that the rest of us have put up. But, they are first-hand experiences with the drug, in real people, severely debilitated by CNS diseases. No one could be more qualified to state, accurately, both the safety and the multiple efficacies of blarcamesine.

Personally, I was delighted when she stated that she very much wishes to take the drug herself, for its various prophylactic benefits; warding off the onset of various geriatric CNS conditions. Some time ago, I was one of the first to claim that this should be considered, that the taking of blarcamesine would some day be common, perhaps universal in late middle age.

But although I’m a research biologist (in an entirely unrelated field), I don’t even know what a blarcamesine pill looks like. I stated my conjectures based upon the detailed biology of blarcamesine; mostly in murines (lab rodents). Dr. Hagerman knows all of that, too. She’s read the same papers I have on blarcamesine biology. She came to the same conclusions I did. Not much attention connected to my conjectures; understood. But the statements of Dr. Hagerman have weight; to come finally into play when the Rett and Parkinson’s disease dementia clinical trials results appear. They will confirm everything all of us here, and Dr. Hagerman, have been proclaiming.

Let the trials conclude!